Zenith Jove Peptide ZJ
Finnrick has tested 32 samples from Zenith Jove Peptide ZJ across 2 products.
Finnrick Vendor Profile
to
Zenith Jove Peptide ZJ
Tracking 2 products
32 total samples tested
Last test 29 Mar 2026
Take Action
Test My Sample
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Products
| Tests | ||||||||
|---|---|---|---|---|---|---|---|---|
| Product | Rating | Count | Avg | Min | Max | Oldest | Most Recent | |
| Retatrutide | 13 | 16 Dec 2025 | 29 Mar 2026 | |||||
| Tirzepatide | 19 | 11 Dec 2025 | 13 Mar 2026 | |||||
The Zenith Jove Peptide ZJ samples tested by Finnrick were either acquired by Finnrick directly, or submitted by the public.
Customer Reviews
These indicators of customer satisfaction are based on reports submitted by the public through the Finnrick testing program, and are not verified.
4.9
Based on 23 overall satisfaction reports
Ease of Purchase4.8(23)
Payment Methods4.7(23)
Delivery Speed4.7(23)
Packaging Quality4.8(22)
Customer Service4.8(23)
People who submitted test requests to Finnrick gave Zenith Jove Peptide ZJ an average satisfaction rating of 4.9 out of 5 across 23 reports associated with samples received and tested by Finnrick.
Most recent Zenith Jove Peptide ZJ tests
Samples are tested in commercial labs
32
tests
2
products
Scores
AVGMINMAX
First
11 Dec 2025
Last
29 Mar 2026
| Quantity | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Product | Certificate | Test Score | Label | Tested | Difference | Purity | Endotoxins | Batch ID | Container | Tested At | Sent By |
| 29 Mar 2026 | Retatrutide | View | 10mg | 11.3mg | +13.0% | 99.70% | n/a | (no batch ID) | Green Label / Silver Crimp / Green Cap | Lab G | Public | |
| 25 Mar 2026 | Retatrutide | View | 20mg | 21.4mg | +7.0% | 99.90% | n/a | (no batch ID) | No Label / Silver Crimp / Violet Cap | Lab G | Public | |
| 19 Mar 2026 | Retatrutide | View | 30mg | 29mg | -3.3% | 99.90% | n/a | (no batch ID) | Black Label / Silver Crimp / Black Cap | Lab E | Public | |
| 19 Mar 2026 | Retatrutide | View | 10mg | 10.1mg | +1.0% | 99.90% | n/a | RT10-greencap-Jan2026 | No Label / Silver Crimp / Green Cap | Lab E | Public | |
| 13 Mar 2026 | Tirzepatide | View | 20mg | 21.2mg | +6.0% | 99.80% | n/a | 02/03/2026 - Gray cap | No Label / Silver Crimp / Gray Cap | Lab G | Public | |
| 3 Mar 2026 | Tirzepatide | View | 15mg | 19.6mg | +30.7% | 98.80% | below LOQ | PLC-TR15-01-26 | No Label / Silver Crimp / Blue Cap | Lab E | Public | |
| 2 Mar 2026 | Retatrutide | View | 10mg | 9.91mg | -0.9% | 99.90% | below LOQ | (no batch ID) | No Label / Silver Crimp / Green Cap | Lab E | Public | |
Corrections
- 25 Mar 2026: Tirzepatide
- Sample ef8mddf (Tirzepatide) and ryusy8h (Semaglutide) were reported by the submitter as mixed up, resulting in the incorrect test being run. However, Finnrick believes that such a mistake could have happened at the time of actually using the samples, because the vials are unlabeled, and therefore will not re-run the tests or retract the results, beyond the present note.
- 25 Mar 2026: Semaglutide
- Sample ef8mddf (Tirzepatide) and ryusy8h (Semaglutide) were reported by the submitter as mixed up, resulting in the incorrect test being run. However, Finnrick believes that such a mistake could have happened at the time of actually using the samples, because the vials are unlabeled, and therefore will not re-run the tests or retract the results, beyond the present note.